市場調查報告書
商品編碼
1215433
全球肺炎檢測市場規模研究和預測:按產品類型、類型、最終用戶和地區分析,2022-2029Global Pneumonia Testing Market Size study & Forecast, by Product Type by Type, by End-user and Regional Analysis, 2022-2029 |
稱為肺炎的肺部感染是由細菌、真菌或病毒引起的。
肺泡是肺部的氣囊,因液體和膿液而發炎和腫脹。 咳嗽、發燒、發冷和呼吸困難是肺炎最常見的一些症狀。 肺炎檢測□□包括體格檢查、病史、胸部 X 光檢查、血培養、脈搏血氧儀、痰培養、支氣管鏡檢查和液體取樣。 對肺炎的興趣增加導致這種疾病的流行和早期診斷增加。 即時檢驗 (POC) 檢測的普及、核酸檢測技術的進步以及老年人口的增加也是增長的因素。
在預測期內,肺炎患病率的上升將為肺炎檢測市場創造有利可圖的需求。 例如,根據 2019 年聯合國兒童基金會(聯合國國際兒童基金會)的一篇文章,全球每 10 萬人中有超過 1,400 例肺炎病例。 此外,南亞和西非和中非的發病率最高,分別為每 10 萬兒童 2,500 例和 1,620 例。 因此,上述原因已成為市場的重要增長動力。 此外,肺炎檢測技術的進步是有望推動這一增長的關鍵方面之一。 基於先進的多重 PCR (mPCR) 的肺炎診斷技術提供了更高的檢測效率,最大限度地減少了成本和時間。 例如,2018年,在美國,Curetis推出了Unyvero System和LRT Cartridge。 該方法利用強大的多重 PCR 技術輕鬆確定從樣品到反應的各種細菌、抗生素耐藥性指標或毒素。 預計在預測期內,增加護理點 (POC) 測試的利用率也將為市場創造有利可圖的機會。 然而,胸部 X 光作為檢測肺炎的重要工具的廣泛使用阻礙了整個 2022-2029 年預測期內的市場增長。
全球肺炎檢測市場研究中考慮的主要區域是亞太地區、北美、歐洲、拉丁美洲和世界其他地區。 由於肺炎患者人數的增加、有利的報銷政策以及護理點技術的日益普及,北美已成為世界市場份額的主導地區。 另一方面,由於老年人口增加和肺炎患者數量增加等因素,預計亞太地區在預測期內將呈現高增長率,為亞洲肺炎檢測市場創造良好的增長前景-太平洋地區,這是可能的。
這項研究的目的是定義近年來各個細分市場和國家的市場規模,並預測未來幾年的價值。 該報告旨在捕捉被調查國家工業的定性和定量方面的情況。
它還提供了關鍵方面的詳細信息,例如決定市場未來增長的驅動因素和挑戰。 此外,它還包含供利益相關者投資的微觀市場潛在機會,以及對主要參與者的競爭格局和產品供應的深入分析。
Global Pneumonia Testing Market is valued approximately USD XXX billion in 2021 and is anticipated to grow with a healthy growth rate of more than XXX% over the forecast period 2022-2029. A lung infection known as pneumonia is caused by the bacteria, fungus, or viruses. Alveoli, the air sacs in the lungs, become inflamed and swell with fluid or pus as a result of the infection. Cough, fever, chills, and breathing difficulties are a few of the pneumonia symptoms that are frequently seen. Physical examination, evaluation of medical history, chest X-ray, blood culture, pulse oximetry, sputum culture, bronchoscopy, and fluid sample make the pneumonia testing process for this disease. The rise in concerns about pneumonia has led to an increase in the prevalence of the disease and early diagnosis. Also, another factor driving the growth is Increased use of point of care (POC) testing and technological advancements, such as nucleic acid detection worldwide, as well as a growth in the number of geriatric populations.
The rising prevalence of pneumonia will create the lucrative demand for the pneumonia testing market during forecast period. For instance, according to a 2019 UNICEF (United Nations International Children's Emergency Fund) article, there are more than 1,400 cases of pneumonia per 100,000 people worldwide. Additionally, with 2,500 cases and 1,620 cases per 100,000 children, respectively, South Asia and West and Central Africa have the highest incidence of it. Therefore, the above reasons are significant growth drivers for the market. Additionally, technology advancements in pneumonia testing are one of the key aspects that are expected to fuel this growth. Higher detection efficiency is provided by the advanced multiplex PCR (mPCR) based technology for diagnosing pneumonia, which minimizes cost and time. For instance, in 2018, in the US, Curetis launched the Unyvero System and LRT Cartridge. The method utilizes powerful multiplex PCR technology to easily determine a wide range of bacteria, indicators of antibiotic resistance, or toxins from sample to response. Also, rising use of point of care (POC) testing would create the lucrative opportunity for the market during forecast period. However, the widespread utilization of chest X-rays as an essential tool for pneumonia detection stifles market growth throughout the forecast period of 2022-2029.
The key regions considered for the Global Pneumonia Testing Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America is the dominating region across the world in terms of market share, owing to the rising number of pneumonia cases, favorable reimbursement policy and growing adoption of point-of-care technologies. Whereas, Asia Pacific is also anticipated to exhibit highest growth rate over the forecast period, owing to factors such as increasing geriatric population and growing cases of pneumonia would create lucrative growth prospects for the Pneumonia Testing market across Asia Pacific region.
Major market players included in this report are:
Quidel Corporation (U.S.)
Abbott (U.S.)
bioMerieux SA (France)
Thermo Fisher Scientific Inc. (U.S.)
INTEC (China)
OpGen (U.S.)
Meridian Bioscience, Inc. (U.S.)
BD (Becton, Dickinson, and Company) (U.S.)
Luminex Corporation (DiaSorin S.p.A.) (U.S.)
Roche Holding AG (Switzerland)
Recent Developments in the Market:
Global Pneumonia Testing Market Report Scope:
Historical Data: 2019-2020-2021
Base Year for Estimation: 2021
Forecast period: 2022-2029
Report Coverage: Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
Segments Covered: Product Type, Type, End-user, Region
Regional Scope: North America; Europe; Asia Pacific; Latin America; Rest of the World
Customization Scope: Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*
The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.
The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product Type:
Instruments
Reagents & Consumables
By Type:
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others
By End-user:
Hospitals & Clinics
Diagnostic Centers
Others
By Region:
North America
U.S.
Canada
Europe
UK
Germany
France
Spain
Italy
ROE
Asia Pacific
China
India
Japan
Australia
South Korea
RoAPAC
Latin America
Brazil
Mexico
RoLA
Rest of the World
List of tables and figures and dummy in nature, final lists may vary in the final deliverable
List of figures
List of tables and figures and dummy in nature, final lists may vary in the final deliverable